124 related articles for article (PubMed ID: 2834967)
1. Enhanced vasopressin (V2-receptor)-induced sodium retention in mineralocorticoid hypertension.
Jeffries WB; Wang Y; Pettinger WA
Am J Physiol; 1988 May; 254(5 Pt 2):F739-46. PubMed ID: 2834967
[TBL] [Abstract][Full Text] [Related]
2. Enhanced cAMP response to vasopressin in the CCT of DOCA-Na hypertensive rats.
Pettinger WA; Fallet R; Wang Y; Tam LT; Jeffries WB
Am J Physiol; 1986 Dec; 251(6 Pt 2):F1096-100. PubMed ID: 3024505
[TBL] [Abstract][Full Text] [Related]
3. Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension.
Jeffries WB; McArdle S; Bockman C; Abel PW; Pettinger WA
Hypertension; 1991 Jan; 17(1):63-71. PubMed ID: 1846120
[TBL] [Abstract][Full Text] [Related]
4. Chronic V2 vasopressin receptor stimulation increases basal blood pressure and exacerbates deoxycorticosterone acetate-salt hypertension.
Fernandes S; Bruneval P; Hagege A; Heudes D; Ghostine S; Bouby N
Endocrinology; 2002 Jul; 143(7):2759-66. PubMed ID: 12072411
[TBL] [Abstract][Full Text] [Related]
5. Tonic inhibition of renal response to vasopressin by a pertussis toxin substrate.
Jeffries WB; Fallet R; Gong GD; Van Dreal P; Pettinger WA
Am J Physiol; 1988 Dec; 255(6 Pt 2):F1107-15. PubMed ID: 2904771
[TBL] [Abstract][Full Text] [Related]
6. DOCA-enhanced sites of vasopressin-stimulated cAMP formation in rat cortical collecting tubule.
McArdle S; Fallet R; Jeffries WB; Pettinger WA
Am J Physiol; 1992 Dec; 263(6 Pt 2):F1093-7. PubMed ID: 1336310
[TBL] [Abstract][Full Text] [Related]
7. Regulation of vasopressin receptors in deoxycorticosterone acetate-salt hypertension.
Trinder D; Phillips PA; Risvanis J; Stephenson JM; Johnston CI
Hypertension; 1992 Oct; 20(4):569-74. PubMed ID: 1398892
[TBL] [Abstract][Full Text] [Related]
8. Properties of [3H]1-desamino-8-D-arginine vasopressin as a radioligand for vasopressin V2-receptors in rat kidney.
Marchingo AJ; Abrahams JM; Woodcock EA; Smith AI; Mendelsohn FA; Johnston CI
Endocrinology; 1988 Apr; 122(4):1328-36. PubMed ID: 2964362
[TBL] [Abstract][Full Text] [Related]
9. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
Bockman CS; Jeffries WB; Pettinger WA; Abel PW
Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
[TBL] [Abstract][Full Text] [Related]
10. Changes in vascular vasopressin receptors and responsiveness in DOCA/NaCl-treated rats.
Smith CD; Pearlmutter F; Szkrybalo M; Katovich MJ
Clin Exp Hypertens A; 1988; 10(4):629-47. PubMed ID: 2968870
[TBL] [Abstract][Full Text] [Related]
11. [The role of Na+-K+ ATPase activity on blood pressure regulation and sodium metabolism in DOCA-treated rats].
Shigetomi S; Tosaki H; Ueno S; Kohno H; Mori K; Katoh K; Tanaka K; Haga H; Kin S; Matsunaga A
Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1198-207. PubMed ID: 2556303
[TBL] [Abstract][Full Text] [Related]
12. Chronic activation of vasopressin-2 receptors induces hypertension in Liddle mice by promoting Na
Stockand JD; Mironova EV; Xiang H; Soares AG; Contreras J; McCormick JA; Gurley SB; Pao AC
Am J Physiol Renal Physiol; 2022 Oct; 323(4):F468-F478. PubMed ID: 35900342
[TBL] [Abstract][Full Text] [Related]
13. Vascular binding sites and biological activity of vasopressin in DOCA-salt hypertensive rats.
Larivière R; St-Louis J; Schiffrin EL
J Hypertens; 1988 Mar; 6(3):211-7. PubMed ID: 3283226
[TBL] [Abstract][Full Text] [Related]
14. Arginine vasopressin increases intracellular calcium ion concentration in isolated mouse collecting tubule cells: distinct mechanism of action through V2 receptor, but independent of adenylate cyclase activation.
Naruse M
Nihon Jinzo Gakkai Shi; 1992 Apr; 34(4):337-47. PubMed ID: 1635278
[TBL] [Abstract][Full Text] [Related]
15. Complete dissociation of DOCA-salt hypertension and red cell ion transport alterations.
Bin Talib HK; Kunes J; Zicha J
Life Sci; 1992; 51(24):PL243-8. PubMed ID: 1447948
[TBL] [Abstract][Full Text] [Related]
16. Low-dose desmopressin infusion: renal action in healthy women in moderate salt retention and depletion, and interactions with prostanoids.
Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
Prostaglandins Leukot Essent Fatty Acids; 2002 Oct; 67(4):263-73. PubMed ID: 12401441
[TBL] [Abstract][Full Text] [Related]
17. Collecting duct sodium reabsorption in deoxycorticosterone-treated rats.
Haas JA; Berndt TJ; Youngberg SP; Knox FG
J Clin Invest; 1979 Feb; 63(2):211-4. PubMed ID: 429550
[TBL] [Abstract][Full Text] [Related]
18. Roles of brain angiotensin II and C-type natriuretic peptide in deoxycorticosterone acetate-salt hypertension in rats.
Nishimura M; Ohtsuka K; Sakamoto M; Nanbu A; Takahashi H; Yoshimura M
J Hypertens; 1998 Aug; 16(8):1175-85. PubMed ID: 9794722
[TBL] [Abstract][Full Text] [Related]
19. Endothelium, vasopressin receptors, and resistance to DOCA-salt hypertension.
Bockman CS; Jeffries WB; Pettinger WA; Abel PW
Am J Physiol; 1993 Jul; 265(1 Pt 2):H15-21. PubMed ID: 8342627
[TBL] [Abstract][Full Text] [Related]
20. Effects of DDAVP and AVP on sodium and water balance in conscious rat.
Gross PA; Anderson RJ
Am J Physiol; 1982 Nov; 243(5):R512-9. PubMed ID: 7137381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
